The Lancet Gastroenterology & Hepatology in conversation with

Colorectal cancer risk in patients with Crohn’s disease

The Lancet

Ola Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease.

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv